If T cells require specific interactions with MHC-bound peptides during positive selection, then the specificities of T cells selected by one peptide should be distinct from those selected by another. We have examined positive selection of CD4 T cells in four strains of mice, each overexpressing a different peptide-1-A b (A b ) complex. We show that a subset of CD4 T cells is selected by the overexpressed peptide and that the specificities of the CD4 T cells, as measured by reactivity to wild-type antigen-presenting cells, vary greatly depending on which peptide is overexpressed. These differences in specificity are mediated through positive selection not negative selection. Each of the four peptide-A b complexes appears to adopt a different conformation, and these differences correlate with the differences in reactivity. Our results suggest that individual peptide-MHC complexes positively select different subsets of self-MHC-reactive T cells and that the conformation of the peptide-MHC complex may contribute to this process.
We show that a subset of CD4 T cells is selected by the overexpressed peptide and that the specificities of the CD4 T cells, as measured by reactivity to wild-type antigen-presenting cells, vary greatly depending on which peptide is overexpressed. These differences in specificity are mediated through positive selection not negative selection. Each of the four peptide-A b complexes appears to adopt a different conformation, and these differences correlate with the differences in reactivity. Our results suggest that individual peptide-MHC complexes positively select different subsets of self-MHC-reactive T cells and that the conformation of the peptide-MHC complex may contribute to this process.
thymus ͉ CD4 T cells ͉ development ͉ T cell specificity ͉ mice I n the thymus, T cells are evaluated on the basis of the reactivity of their T cell receptors (TCRs) for self-peptides bound to self-MHC molecules. Although strongly reactive cells are eliminated through negative selection, weakly reactive cells are positively selected to mature and exit to the periphery. Collectively, these processes result in a T cell repertoire with the greatest capacity to respond to foreign peptides bound to self-MHC (1, 2) . Although it is clear that interaction between the TCR and MHC-bound self-peptides is required during the positive selection of T cells, the specificity of this interaction has not been agreed upon. Recently, this debate has centered around analyses of the development of CD4 T cells in mice engineered to express a single peptide bound to their MHC class II molecules. Several groups have shown that large numbers of CD4 T cells (20-40% of wild type, depending on the system) are present in H-2M-deficient (H-2M 0 ) and AbEp mice and that the repertoire of T cells in these mice is quite broad (3) (4) (5) (6) (7) (8) . Consequently, these authors have suggested that the recognition of peptides during positive selection is promiscuous (9, 10) .
In subsequent work, we and others have argued that many T cells are selected on diverse, low-abundance peptides (11) (12) (13) . It was shown most directly by using mice that express a human invariant chain (Ii) transgene (Tg) in which class II-associated invariant chain peptide (CLIP) has been replaced with E␣ peptide. The Tg rescues class II expression to wild-type levels when expressed in Ii-deficient (E␣-Ii 0 ) mice, and E␣ peptide is bound to Ϸ95% of class II molecules (12) . Although this class II expression is sufficient to select a full compartment of CD4 T cells, selection of the majority of these cells depends on non-E␣ peptides. When the Tg is expressed in mice that also lack H-2M (E␣-dbl 0 ), these non-E␣ peptides are no longer detectable, and the number of CD4 T cells drops to 30% of that seen in E␣-Ii 
Materials and Methods
Mice. The human genomic Ii cassette and the generation of Ii-E␣ mice have been described elsewhere (12, 14) . To generate Ii-CD22 and Ii-Rab transgenic mice, purified Ii-peptide DNA was injected into BDF1 ϫ Ii Abbreviations: TCR, T cell receptor; Ii, human invariant chain; Tg, transgene; CLIP, class II-associated invariant chain peptide; BM, bone marrow; APC, antigen-presenting cell.
, or H10 (Rab-A b ) followed by streptavidin-FITC (Vector Laboratories). Thymocytes or splenocytes were incubated on ice with anti-CD4-phycoerythrin, anti-CD8␣-FITC, and anti-TCR␤-biotin mAbs (all from PharMingen) followed by streptavidinTricolor (Caltag, South San Francisco, CA). Stained cells were analyzed by using a FACScalibur flow cytometer and CELLQUEST software (Becton Dickinson).
Titrated numbers of erythrocyte-depleted splenocytes were cultured with 10 5 T cell hybrids for 18-20 h. Production of IL-2 in the supernatants was measured by a standard HT-2 cell assay by using Alamar blue (11) . Data are presented as a mean OD 570͞600 of duplicate cultures.
Western Blot Analysis. C57BL͞6, E␣-dbl 0 , CD22-dbl 0 , Rab-dbl 0 , or H-2M 0 splenocyte lysates (0.5% Nonidet P-40͞150 mM NaCl͞5 mM EDTA͞50 mM Tris, pH 7.2) were resolved on nonreducing 8% SDS polyacrylamide gels and transferred to nitrocellulose. The blots were probed with rabbit antisera against the cytoplasmic tails of A b ␣ and ␤ chains followed by donkey anti-rabbit horseradish peroxidase or 25-9-17s supernatant followed by sheep anti-mouse Ig-horseradish peroxidase (Amersham Pharmacia). Bone-Marrow (BM) Chimeras. BM chimeras were generated as described (11) . Lethally irradiated (1,000 rad) recipient mice received 2. wild-type levels when expressed in Ii 0 and dbl 0 mice. To assess expression of the CD22 and Rab peptides, we generated two new peptide class II-specific mAbs, A8 and H10, respectively. Using these new reagents, as well as the previously characterized antibodies YAe and 15G4, which recognize E␣-A b and CLIP-A b , respectively, we analyzed the expression of each specific peptide-A b complex. Splenocytes from each of the Ii-peptide transgenic mice stained brightly with the appropriate peptide-specific mAb, indicating that each of the peptides is presented at high levels (Fig. 1B) . As expected, splenocytes from the transgenic mice did not stain with the 15G4 mAb, specific for CLIP-A b , whereas splenocytes from H-2M 0 mice stained strongly with this antibody. Analysis of thymic sections by immunohistochemistry showed that total A b levels and the expression of all three specific peptide-A b complexes were similar to that seen on splenocytes for each of the transgenic mice (data not shown). We have obtained consistently high expression of each Tg in a total of 14 transgenic founder lines with a genomic Ii construct. Importantly, we have not seen variation in expression among different transgenic constructs or founders that is characteristic of the Ii-E␣ promotercontaining cDNA cassette, which has been used by others in related studies (17) .
We used a panel of T cell hybridomas specific for different self-peptide-A b complexes to determine whether additional peptides were detectable in each of the Ii-peptide transgenic mice. Splenocytes from E␣-Ii 0 , CD22-Ii CD4 T Cell Development in Ii-Peptide Transgenic Mice. We previously described how the differences in presentation of non-E␣ peptides between E␣-Ii 0 and E␣-dbl 0 mice impact positive selection of CD4 T cells. In E␣-Ii 0 mice the number of CD4 T cells in the thymus, spleen, and lymph nodes is normal, whereas the number of CD4 T cells in E␣-dbl 0 mice is reduced (12) . We found similar defects in the number of CD4 T cells from 6-8-week-old CD22-dbl 0 and Rab-dbl 0 mice when we analyzed CD4 and CD8 expression on thymocytes and splenocytes by flow cytometry (Fig. 2) . The percentages of CD4 single-positive thymocytes and CD4-positive splenocytes were reduced to 20-30% of that seen in the corresponding peptide-Ii 0 mice. Comparably high proportions of CD44 hi CD4 T cells (48-65%) were found in the periphery but not in the thymus of all three lines of peptide-dbl 0 mice.
These results demonstrate that each of these abundant peptides is not capable of positively selecting the large numbers of . These mice express both E␣ and CLIP peptides at high levels, as measured by the YAe and 15G4 antibodies (Fig. 3) . We compared multiple littermates of the three possible genotypes from that cross at 6-8 weeks of age to determine the effect of additional peptides on CD4 T cell development. In the thymus we detected a statistically significant increase in the percentage of CD4 single-positive thymocytes between E␣-dbl 0 and E␣ ϫ CLIP mice (P Ͻ 0.03) as well as between Ii ϩ͞Ϫ H-2M 0 and E␣ ϫ CLIP mice (P Ͻ 0.025). An increase was observed also when the percentages of splenic CD4 T cells were compared among the three genotypes. These differences were apparent also when the total numbers of CD4 T cells were compared. There was no statistically significant difference in the CD8 T cell compartments between the three types of mice in either the thymus or the spleen. Analysis of individual littermates revealed that the mean fluorescence intensity of Y3P staining of A b molecules on ''single'' and ''double'' E␣ ϫ CLIP peptide splenocytes was comparable [average mean fluorescence intensity: 1,300.5 Ϯ 177.08 (n ϭ 8) for singlepeptide mice and 1,087.13 Ϯ 157.14 (n ϭ 6) for double-peptide mice].
The increase in the number of CD4 T cells caused by overexpression of two peptides provides convincing evidence that a subset of CD4 T cells is selected by the overexpressed peptides in these mice. The fact that this increase is relatively small, however, implies that additional background peptides are present in these mice and that they contribute to positive selection. If the overexpressed peptides were selecting a majority of the CD4 T cells, we would expect to see a larger increase in the total number of CD4 T cells. Importantly, though, we are able to account for CD4 T cells that depend on the overexpressed peptide for selection.
Analysis of the Specificity of CD4 T Cells Selected in Ii-Peptide
Transgenic Mice. We next examined whether these overexpressed peptides altered the specificity of CD4 T cells. First we compared proliferative responses of CD4 T cells to specific A b -binding peptides derived from ovalbumin and hen-egg lysozyme ( Fig. 4A ; data not shown). E␣-dbl 0 , CD22-dbl 0 , and H-2M 0 mice were able to generate CD4 T cells specific for each peptide tested. This result suggests that the T cell repertoire in these mice is not skewed so severely as to limit recognition of specific antigenic peptides. Next we compared the reactivity of CD4 T cells from H-2M , and B6 splenocytes (data not shown).
The differences in reactivity among the three peptide-dbl 0 and H-2M 0 mice could be mediated through differences in negative or positive selection. To distinguish between these two possibilities, we generated BM chimeric mice from H-2M 0 and E␣-dbl These results suggest that each of the four overexpressed peptides positively select TCRs with different specificities, as measured by proliferation against wild-type APCs. In support of this conclusion, we also observed differences in proliferation of CD4 T cells from each of the peptide-Ii 0 mice (Fig. 4D) . Importantly, the relative proliferation between these mice agreed with the differences we had observed among the peptidedbl 0 mice; CD4 T cells from Rab-Ii Together, these data support the conclusion that each overexpressed peptide selects a different subset of CD4 T cells. In peptide-dbl 0 mice, these cells comprise a greater proportion of total CD4 T cells and are subjected to less stringent negative selection by ''background'' peptides than in peptide-Ii 0 , resulting in an overall greater proliferation.
To demonstrate directly that the differences in T cell reactivity were caused by selection on the overexpressed peptides, we performed in vivo mAb blocking of E␣-A b and CLIP-A complexes in E␣ ϫ CLIP mice (see Fig. 6 , which is published as supporting information on the PNAS web site, www.pnas.org). In this experiment, E␣ ϫ CLIP neonates were injected i.p. on the day of birth and every other day thereafter with 200 g of YAe mAb (specific for E␣-A b ), a mixture of 15G4 and 30-2 mAb (specific for CLIP-A b complexes), or normal mouse IgG as a control. After 3-3.5 weeks of treatment, reactivity of splenic CD4 T cells against B6 splenocytes was tested. Antibody treatment did not affect the size of splenic CD4 T cell populations (4.84-6.44% of total splenocytes). However, analysis of total splenocytes from E␣ ϫ CLIP mice treated with the YAe mAb showed a markedly increased CD4 T cell reactivity against B6 splenocytes versus those derived from control mice. In contrast, 15G4͞30-2 treatment resulted in a substantial decrease in CD4 T cell reactivity against B6 splenocytes. Thus, qualitatively blocking one peptide led to selection of T cells with reactivities associated with the other, unblocked peptide. This result directly implicates the major peptide-MHC class II complexes in selecting CD4 T cells with a different reactivity against Ii-A , and H-2M 0 mice indicated that these differences in mobility cannot be explained by different lengths or charges of peptides (see Fig. 7 , which is published as supporting information on the PNAS web site).
The specific peptide-A b complexes could be discriminated further by using two conformation-dependent A b -specific antibodies: BP107 and 25-9-17s. These antibodies stain wild-type splenocytes but not CLIP-A b or E␣-A b complexes, respectively, suggesting that their binding may have certain structural requirements that are not fulfilled by these particular peptide-A b complexes (6, 18) . In support of this idea, we found that BP107 stained E␣-dbl 0 and Rab-dbl (Fig. 6A) . This differential staining when considered together with the unique mobility of each complex in acrylamide gels supports the possibility that each of these particular peptide-A b complexes may be structurally distinct. Interestingly, these differences in gel mobility correlate with the differences in reactivity that we observed between Ii-peptide and H-2M 0 mice. 
Discussion
The degree to which thymocytes depend on specific interactions with MHC-bound self-peptides for positive selection is central to understanding how the T cell repertoire is generated. This issue has direct bearing on the number of T cells that are selected by an individual peptide and the extent to which the specificities of those selected T cells will depend on the peptide. In mice overexpressing individual peptides, we show that a subset of T cells is selected by the abundant peptide as suggested by an increase in the percentage of CD4 single-positive thymocytes when two peptides, E␣ and CLIP, are overexpressed together. Thus, although peptide diversity is required for efficient positive selection, we can detect CD4 T cells selected on a given peptide-A b complex.
Merely measuring cell number, however, ignores differences in the specificities of the selected T cells. The TCR repertoire clearly is altered in mice with limited peptide diversity. Of six TCRs capable of being selected in wild-type mice, only one, DO11.10, has been found to be selected in H-2M 0 mice, although this receptor actually is negatively selected in wild-type H-2 b mice (3, 4, 11, 19) . Recent analysis of the CDR3 sequences within V␣2J␣4 TCR␣ chains from transgenic V␤8.2 CD4 T cells selected on wild-type or H-2M 0 peptide repertoires showed a severe restriction in CDR3 usage caused by the limited peptides in H-2M 0 mice (20) . Similarly, several groups have analyzed TCR sequences in AbEp mice and were able to show alterations because of the overexpression of E␣ peptide or its variant (21) (22) (23) . Thus, the TCRs present in H-2M 0 and AbEp mice clearly are distinct from those in wild-type mice. The limitation inherent to all but one of these analyses, though, is that alterations in specificity cannot be attributed definitively to selection on CLIP and ⌭␣ as opposed to other less abundant self-peptides, nor can they be attributed to positive selection as opposed to negative selection.
We show that the ability of the CD4 T cells in peptide-dbl 0 mice to recognize self-MHC class II molecules displayed by wild-type APCs changes depending on the identity of the overexpressed peptide, and these differences are dictated by positive rather than negative selection (Fig. 4) . The high reactivity of CD4 T cells from H-2M 0 and AbEp mice has been attributed to a lack of negative selection (3) (4) (5) (6) (7) (8) . Indeed, T cells from mice expressing low levels of MHC class II molecules exclusively on thymic cortical epithelial cells are highly self-MHC-reactive (24) . Nevertheless, our results demonstrate that the specificity, i.e., self-MHC reactivity, of T cells can be altered when a single abundant peptide is replaced by another peptide.
It is highly unlikely that the differences in reactivity that we observe are caused by differences in minor peptides that we cannot measure. First, the overexpressed peptides all bind A b with very similar affinity and are expressed at similarly high levels, as measured by peptide-specific antibodies. Second, the Ii-peptide constructs are processed similarly as suggested by identical Ii-derived N-and C-terminal residues in major peptides isolated from peptide-Ii 0 and peptide-dbl in E␣ ϫ CLIP mice by using complex-specific mAbs resulted in CD4 T cell reactivity patterns qualitatively similar to those observed in H-2M 0 and E␣-dbl 0 mice, respectively. In aggregate, these results strongly suggest that the overexpressed peptide-A b complexes are directly responsible for selection of self-MHC-reactive CD4 T cells with a differing degree of reactivity.
It is puzzling why CD4 T cells from CD22-dbl 0 mice, and to a lesser extent E␣-dbl 0 mice, have such low self-MHC reactivity. In all four strains of mice, negative selection is likely to be similarly inefficient because of the severe reduction in endogenous peptides presented by A b (Fig. 2) . We ruled out the possibility that regulatory T cells were inhibiting proliferation in the less reactive mice (data not shown). Therefore, we can speculate that the differing degrees of self-MHC reactivity displayed by each strain of mice suggest that varying numbers of self-MHC-reactive cells may be positively selected on each of the different peptide-A b complexes. Alternatively, the same approximate number of self-MHC-reactive cells may be selected in each strain of mice, but certain peptide-A b complexes (e.g., CLIP-A b ) simply may select much more highly reactive TCRs than others (e.g., CD22-A b ). Either possibility implies that certain peptide-A b complexes select MHC-reactive cells more efficiently than others. In support of this conclusion, MHC-reactive cells from H-2M 0 mice have a weaker affinity for H-2 b APCs than for H-2 bm12 APCs, and they suggest that high-affinity cells may not be positively selected by CLIP-A b because of its high expression (25) . In light of our results, it seems more likely that different peptide-A b complexes may select different subsets of MHC-reactive T cells capable of recognition of self-MHC class II molecules bound to a diverse repertoire of peptides. We predict that TCRs displayed by such T cells have less stringent peptide specificity and depend more on interactions with MHC residues as compared with peptide-specific T cells. Importantly, polyclonal peptide-specific CD4 T cell responses are not significantly different in Ii-peptide transgenic mice.
What makes these different peptide-A b complexes biologically distinct? The most straightforward explanation is that the differences in the four peptide sequences are mediating differential selection of certain TCR specificities. However, it is possible that the conformation of a given peptide-A b complex may affect interactions with certain TCRs (18) . It is tempting to invoke possible conformational differences among the four peptide-A b complexes to explain a greater or lesser propensity for self-MHC reactivity. In fact, we have observed that each of the four peptide-A b complexes appears to adopt a distinct conformation (Fig. 5) . It is possible that certain conformations are better at selecting self-MHC-reactive T cells than others. Indeed, Rab-A b complexes have gel mobility most similar to CLIP-A b , and T cells from these mice are the most reactive of the three peptide-dbl 0 mice. Clearly, the self-MHC reactivity observed in CD4 T cells from peptide-dbl 0 or peptide-Ii 0 mice is not equivalent to the autoreactivity observed in experimental or clinical autoimmunity. However, it seems reasonable to suggest that our findings are applicable to ligands that positively select pathogenic T cells in autoimmune settings.
